Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 4th May 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Liverpool antibiotic research receives funding boost
SPR206 may be safer and just as effective as colistin.
Funding will support the development of SPR206

A grant of £250k has been awarded to the University of Liverpool to develop antibiotics for multi-drug resistant bacteria.

The money, awarded by biopharmaceutical company Spero Therapeutics, will be used by the University’s Centre for Antimicrobial Pharmacodynamics (CAP) for the development of SPR206.

Initial research suggests this new antibiotic may be safer and just as effective as colistin. In the NHS, colistin is only used as a last resort treatment of multi-drug resistant bacteria because it is highly toxic.

The research will be conducted by Dr Shampa Das and Professor William Hope.

Professor Hope said: “This funding will help support further work of the CAP, where the principal task is to identify regimens to take into first-in-patient clinical studies.”

The discovery of SPR206 and its development is being supported by the National Institute for Allergy and Infectious Diseases, National Institutes of Health. 

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.